Fractyl Health, Inc.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Operating Activities | |||
| Net Income | $-141.0M | $-68.7M | $-77.1M |
| Depreciation & Amortization | — | — | — |
| Depreciation | $1.1M | $677.0K | $286.0K |
| Amortization | — | — | — |
| Stock-Based Compensation | $6.7M | $14.4M | $4.3M |
| Net Cash from Operating Activities | $-90.3M | $-65.5M | $-42.8M |
| Investing Activities | |||
| Capital Expenditures | $557.0K | $1.8M | $359.0K |
| Business Acquisitions | — | — | — |
| Net Cash from Investing Activities | $-557.0K | $-1.8M | $-359.0K |
| Financing Activities | |||
| Dividends Paid | — | — | — |
| Stock Repurchases | — | — | — |
| Net Cash from Financing Activities | $105.0M | $101.2M | $27.4M |
| Net Change in Cash | $14.1M | $33.9M | $-15.7M |
| Free Cash Flow | $-90.9M | $-67.3M | $-43.2M |